Harnessing the Power of AI to Speed Drug Discovery and Development
By Newsroom editorial staff
Lundbeck and a data-driven drug design company are collaborating to utilize AI to identify clinical candidates for brain disorder therapies.

ABOUT THE NEWSROOM

Here you will find media contacts, plus the latest news, stories and insights from Lundbeck US. Lundbeck is a global pharmaceutical company solely focused on the brain, and our 900+ U.S. employees are committed to improving the lives of people affected by psychiatric and neurological disorders.